OVID - Ovid Therapeutics Inc.

QQQ $ 454.82 $ 4.29 (0.95 %)

DIA $ 398.57 $ -0.02 (-0.01 %)

SPY $ 530.36 $ 3.48 (0.66 %)

TLT $ 91.26 $ 0.27 (0.3 %)

GLD $ 225.37 $ 0.20 (0.09 %)

Previous Close

$ 3

Open

$ 3.02

Bid

$ 0.00 x 0

Ask

$ 3.02 x 129

Day's Range

$ 2.99 - $ 3.04

52 Week Range

$ 2.57 - $ 4.14

Volume

113,605

Average Volume

Market Cap

212.15M

Beta (5Y Monthly)

$ 0.82

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-08-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	03-13-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-15-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-15-2021	12-31-2020	10-K
15	11-13-2020	09-30-2020	10-Q
16	08-10-2020	06-30-2020	10-Q
17	05-07-2020	03-31-2020	10-Q
18	03-11-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-08-2018	03-31-2018	10-Q
26	03-29-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	06-13-2017	03-31-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Ovid...
05/16/2024 11:07:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Ovid Therapeutics (NASDAQ:OVID) with a Buy and maintains $9 pr...

Ovid Therapeutics Q1 EPS $(0.17) Beats $(0...
05/14/2024 12:19:53

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0...

Cracking The Code: Understanding Analyst R...
05/07/2024 19:00:38

Citigroup Maintains Neutral on Ovid Therap...
05/07/2024 17:42:09

Citigroup analyst Yigal Nochomovitz maintains Ovid Therapeutics (NASDAQ:OVID) with a Neutral and lowers the price target fro...

B. Riley Securities Initiates Coverage On ...
04/30/2024 12:34:48

B. Riley Securities analyst Kalpit Patel initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announc...

HC Wainwright & Co. Initiates Coverage On ...
04/29/2024 10:12:47

HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating a...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
04/24/2024 12:06:37

Wedbush Initiates Coverage On Ovid Therape...
04/05/2024 08:53:15

Wedbush analyst Laura Chico initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Outperform rating and announces Pri...

over-2m-bet-on-nextnav-check-out-these-3-penny-stocks-insiders-are-aggressively-buying

Over $2M Bet On NextNav? Check Out These 3...
03/21/2024 10:45:35

The Dow Jones index closed higher by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their co...

Recap: Ovid Therapeutics Q4 Earnings
03/08/2024 13:05:10

Ovid Therapeutics Q4 2023 GAAP EPS $(0.220...
03/08/2024 13:04:56

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.220) per share which missed the analyst consensus estimate of ...

Ovid Therapeutics Filed U.S. Patent Applic...
01/11/2024 15:49:58

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240009160

BTIG Initiates Coverage On Ovid Therapeuti...
12/21/2023 12:14:11

BTIG analyst Thomas Shrader initiates coverage on Ovid Therapeutics (NASDAQ:OVID) with a Buy rating and announces Price Targ...

Ovid Therapeutics Inc Says May Offer And S...
11/15/2023 21:17:59

-SEC Filing

Ovid Therapeutics Inc Files For Mixed Shel...
11/03/2023 20:12:30

- SEC Filing

Ovid Therapeutics Q3 EPS $(0.16) Beats $(0...
11/03/2023 12:16:52

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0...

Ovid Therapeutics and Ligand Pharma Ink a ...
10/18/2023 12:04:44

Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company dedicated to developing medicines that transform the lives of...

Marinus Pharmaceuticals Said On August 17,...
08/21/2023 11:05:47

-8-K

Ovid Therapeutics' Q2 Cash, Cash Equivalen...
08/04/2023 12:06:20

Ovid Therapeutics Q2 EPS $(0.18) Beats $(0...
08/04/2023 12:05:05

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0...